Latest Kratom Study Unlikely To Change FDA Stance

Critics expect FDA already has reached conclusion about compelling making kratom a controlled substance. “Their conclusion seems to be pretty well preordained,” says NPA CEO Daniel Fabricant.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation